METROPOLITAN LIFE INSURANCE CO/NY - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,472
-27.8%
5,553
+5.7%
0.00%
-25.0%
Q2 2023$85,167
+496.8%
5,254
+10.4%
0.00%
+300.0%
Q1 2022$14,271
-79.7%
4,757
-68.9%
0.00%0.0%
Q4 2021$70,375
-38.0%
15,299
-15.4%
0.00%
-50.0%
Q3 2021$113,536
+98.3%
18,079
+89.1%
0.00%
+100.0%
Q2 2021$57,258
-55.7%
9,559
-53.3%
0.00%
-50.0%
Q1 2021$129,340
+152.6%
20,449
+124.8%
0.00%
+100.0%
Q4 2020$51,205
-38.3%
9,095
-36.3%
0.00%0.0%
Q3 2020$83,040
-46.9%
14,268
-34.2%
0.00%
-66.7%
Q2 2020$156,291
+53.5%
21,677
-0.4%
0.00%
+50.0%
Q1 2020$101,823
-38.5%
21,757
+5.4%
0.00%
-33.3%
Q4 2019$165,605
+13.8%
20,649
-2.4%
0.00%
+50.0%
Q3 2019$145,553
-17.1%
21,1560.0%0.00%
-33.3%
Q2 2019$175,595
-12.2%
21,156
+5.1%
0.00%
-25.0%
Q1 2019$200,072
+19.3%
20,128
-8.2%
0.00%
+33.3%
Q4 2018$167,703
-37.2%
21,922
+43.1%
0.00%
-40.0%
Q3 2018$266,927
-99.8%
15,3230.0%0.01%
+150.0%
Q2 2018$145,415,00015,3230.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$2,613,0006.32%
Opaleye Management Inc. 825,000$14,371,0003.66%
Prosight Management, LP 274,410$4,780,0002.66%
SPHERA FUNDS MANAGEMENT LTD. 859,727$14,976,0001.72%
KNOTT DAVID M 236,600$4,122,0001.34%
Sio Capital Management, LLC 213,252$3,715,0001.28%
NEXTHERA CAPITAL LP 327,730$5,709,0001.09%
EAM Global Investors LLC 115,781$2,017,0000.82%
Nicholas Investment Partners, LP 580,028$10,104,0000.81%
Park West Asset Management LLC 1,269,107$22,108,0000.80%
View complete list of VIKING THERAPEUTICS INC shareholders